The integrated network, made available as a visualization tool for the scientific community, not only enhances our understanding of the Aβ-tau interaction but also provides a basis for generating experimental validation ideas and developing more effective treatments for AD. The gene discussed is MAPT; the disease is Alzheimer disease.